Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028337 · ClinicalTrials.gov registry record · Phase 2
Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases
A Phase 2 study of Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03028337 is a Phase 2 study of Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03028337, a Phase 2 study of Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to learn whether delivering spine radiosurgery in a single large dose is better than delivering spine radiosurgery over 3 smaller doses. Researchers also want to learn about the effects of a single dose on participant's symptoms, pain, and quality-of-life.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- RADIATION Spine Radiosurgery
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-01-18 |
| Est. Completion | 2028-05-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03028337
The ClinicalTrials.gov registry entry for NCT03028337 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT03028337 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03028337 about?
NCT03028337 is a clinical study titled "Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases". The goal of this clinical research study is to learn whether delivering spine radiosurgery in a single large dose is better than delivering spine radiosurgery over 3 smaller doses. Researchers also want to learn about the effects of a single dose on participant's symptoms, pain, and quality-of-life...
What is the current status of trial NCT03028337?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2017-01-18. Estimated completion is 2028-05-30.
What conditions does trial NCT03028337 study?
This clinical trial studies the following conditions: Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System.
What interventions are being tested in trial NCT03028337?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Spine Radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT03028337?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03028337 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.